ARCH Venture Partners

ARCH Venture Partners is a premier provider of seed and early stage venture capital for technology firms, with a special competence in co-founding and building firms from start-up.

Our mission is to deliver promising technologies from the earliest stages to successful commercial application – from concept to commerce.

With a 30 year history and $2 billion in capital under management, ARCH has secured its place among the largest providers of seed and early stage capital in the U.S.

TypeInvestor
HQChicago, IL, US
Founded1986
Websitearchventure.com
Cybersecurity ratingAMore
ARCH Venture Partners was founded in 1986 and is headquartered in Chicago, IL, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at ARCH Venture Partners

Kristina Burow

Kristina Burow

Managing Director
Robert Nelsen

Robert Nelsen

Co-Founder & Managing Director
Keith Crandell

Keith Crandell

Co-Founder & Managing Director
Steve Gillis

Steve Gillis

Managing Director
Clinton Bybee

Clinton Bybee

Co-founder & Managing Director, Emeritus
Paul Thurk

Paul Thurk

Managing Director
Show more

ARCH Venture Partners Office Locations

ARCH Venture Partners has offices in Chicago, San Francisco and Seattle
Chicago, IL, US (HQ)
8755 W Higgins Rd #1025
San Francisco, CA, US
1700 Owens St #535, San Francisco
Seattle, WA, US
188 E Blaine St #125
Show all (3)

ARCH Venture Partners Investment Portfolio

Stage Distribution

19982021

Top Sectors Distribution

20002021

Round Size Distribution

19982021
Show more

ARCH Venture Partners News and Updates

Chinese drug maker SciNeuro Pharma raises $100m co-led by LAV, Arch Venture Partners

General Atlantic, and Sequoia Capital China also invested in the round. The post Chinese drug maker SciNeuro Pharma raises $100m co-led by LAV, Arch Venture Partners appeared first on DealStreetAsia.

ARCH Venture Partners Online and Social Media Presence

Embed Graph

ARCH Venture Partners Blogs

Prime Medicine raises $315M to fuel ‘search-and-replace’ gene editing work

The post Prime Medicine raises $315M to fuel ‘search-and-replace’ gene editing work appeared first on Arch Venture Partners.

Global Business Reports: U.S. Pharmaceutical and Biopharmaceutical Industry Report. An interview with Keith Crandell.

The post Global Business Reports: U.S. Pharmaceutical and Biopharmaceutical Industry Report. An interview with Keith Crandell. appeared first on Arch Venture Partners.

ARCH Leads Series A Round for Treeline Biosciences, New Cancer Biotech

The post ARCH Leads Series A Round for Treeline Biosciences, New Cancer Biotech appeared first on Arch Venture Partners.

Visualizing the Future: Spatialomics Transforms Study of Gene Expression

The post Visualizing the Future: Spatialomics Transforms Study of Gene Expression appeared first on Arch Venture Partners.

ARCH Venture Partners Named to Forbes’ Midas List 2021

The post ARCH Venture Partners Named to Forbes’ Midas List 2021 appeared first on Arch Venture Partners.

‘One Billion Doses On Day One’: Vaccine Company Resilience Claims World-Changing Innovation

The post ‘One Billion Doses On Day One’: Vaccine Company Resilience Claims World-Changing Innovation appeared first on Arch Venture Partners.
Show more

ARCH Venture Partners Frequently Asked Questions

  • When was ARCH Venture Partners founded?

    ARCH Venture Partners was founded in 1986.

  • Who are ARCH Venture Partners key executives?

    ARCH Venture Partners's key executives are Kristina Burow, Robert Nelsen and Keith Crandell.

  • Where is ARCH Venture Partners headquarters?

    ARCH Venture Partners headquarters is located at 8755 W Higgins Rd #1025, Chicago.

  • Where are ARCH Venture Partners offices?

    ARCH Venture Partners has offices in Chicago, San Francisco and Seattle.

  • How many offices does ARCH Venture Partners have?

    ARCH Venture Partners has 3 offices.